Gemcitabine Hydrochloride
Gemcitabine Hydrochloride is a nucleoside analog antineoplastic agent used for solid tumour malignancies including pancreatic and lung cancers.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Gemcitabine Hydrochloride – CAS 122111-03-9
CAS Number
122111-03-9
Category
Oncology
Therapeutic Class
Antineoplastic / Nucleoside analog
Description
Gemcitabine Hydrochloride is a nucleoside analog antineoplastic agent used for solid tumour malignancies including pancreatic and lung cancers.
Applications
- Non-small cell lung cancer
- Pancreatic cancer
- Bladder cancer
- Breast cancer
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.